Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15812833 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed R115777 in Treating Patients With Advanced Bladder Cancer
Conditions: Bladder Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter
Interventions: Drug: chemotherapy;   Drug: tipifarnib

Indicates status has not been verified in more than two years